prevention of placenta-mediated adverse pregnancy outcomes in pregnant patients with antiphospholipid syndrome
All entries for: UCB, Inc.
March 2, 2026
UCB, Inc.
Orphan Drug Designation
Smyrna
1-50 employees
Disease Area: Rare Disease